Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that ...

Moreover, Tenaya’s approach includes broadening its clinical trial reach with the RIDGE-1 Phase Ib trial for TN-401, aimed at treating PKP2-associated arrhythmogenic right ventricular ...

Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies ...

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Tenaya Therapeutics (TNYA – Research Report). The company’s shares opened today at $1.42. According to TipRanks ...

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) released initial results from its phase 1b/2 MyPEAK-1 study, using its gene therapy candidate TN-201 for the treatment of patients with MYBPC3-associated ...

Featured pricing is subject to change. Diamonds are forever. Taylor Swift rocked pricey diamond earrings from De Beers Jewelry during her rainy NYC date night with Travis Kelce on Saturday.

A rep for De Beers tells PEOPLE that they loved seeing the star dazzle in the Arpeggia One Line earrings so much the brand gifted her a pair TheStewartofNY/GC Images; De Beers Taylor Swift is ...

State Street Corp grew its holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) by 0.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange ...

It has a price fitting for the flagship store’s Mayfair location: A pair of small, nine-karat gold hoop earrings cost £795, about $1,000.

Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through gene editing, cellular ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...